The normally rare infection has a 50% mortality rate and is hitting recovering Covid-19 patients.

BBC correspondent Yogita Limaye visits a ward battling India's mucormycosis epidemic in the wake of Covid.

India has seen rising cases of the serious fungal infection, mostly in Covid patients.

The rise in number of mucormycosis cases in India has alarmed experts.

Doctors are seeing an uptick in a host of dangerous fungal infections in recovering ICU patients.

The normally rare infection has a 50% mortality rate, and is hitting recovering Covid-19 patients.

The health authorities ask states to declare an epidemic after a normally rare infection surges.